Thursday, September 23, 2021 12:24:56 PM
Interestingly, there are a number of divergent, otherwise unconnected reasons, I see, that equity buyers have or might decide to take an AVXL position.
1. The Investment Advisor Recommendation. In this case, a recommendation in some investor newsletter, blog, or webpage prompts an AVXL buy. The particular reasons the newsletter or investment advisor states are not as important as the recommendation itself. It comes from “someone who knows,” or has “a good record.” Good enough. “I’ll buy some of those.”
2. The FOMO (fear of missing out) Buy. In whatever way, an equity buyer discovers that, at least for the nonce, the AVXL share price is on a steep ascent. The person wants to catch that rise, so “buys low, to sell higher.” Few or no other data or information come into play.
3. The Day-Trading Play. It is noted that the AVXL share price tends, at times, to sharply ascend, then more slowly drop back to some “base price,” Day traders, expert in spotting and playing these moves, go in an out of AVXL positions, making a few percentage points of gains with each buy/sell trade pair.
4. The Technical Analysis (TA) Play. Those confident in TA see and act on various TA buy or sell signals. Trades are based solely on the AVXL or market TA charts and metrics; nothing else.
5. The Anavex Science and Potential Markets Play. AVXL positions taken with these criteria take into consideration the accuracy, validity, and potential applications of the existing, known ANAVEX science, as revealed in scholarly papers, informed postings, research, and corporate and institutional announcements; while also considering the potential markets for the ANAVEX drugs, once they might gain regulatory approval for sales and therapeutic uses.
Each of these will prompt varying time frames in which AVXL positions might be retained.
In Number 1, Investment Advisor Recommendation, positions may be held for some time, contingent on when the recommendations are to play out. Those are likely months or years.
In Number 2, the FOMO Buys, rather short term, for most. When the price ascent levels, time to take the gain and find another equity moving up rapidly. Of course, for some, the AVXL position is then retained for longer-term gains.
Number 3, Day-Traders, are in and out, often within minutes or hours. Nothing long-term here.
Number 4, TA Analysis plays, are probably a bit longer than day-trading. The charts decide.
Number 5, the Anavex Science and Markets plays, are decidedly long-term. Buy, and hold. Wait. Payoffs somewhere in the future; but particularly rewarding when they eventually happen.
Personally, my few thousand shares of AVXL have been purchased, and are retained, because of Number 5, the science and potential markets of Anavex Life Sciences Corp. I utterly reject all of the others, find nothing useful about them at all. But, I dully respect the many individuals who post messages on each of these. I read, and consider them all (but don’t act on any except the science postings). All good people, here; making this one of the most informative iHub message boards.
Recent AVXL News
- Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/20/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:30:10 AM
- Anavex Life Sciences Announces Expansion of Leadership Team • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:01:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:30 PM
- Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/12/2024 09:45:00 AM
- Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL • PR Newswire (US) • 04/05/2024 09:45:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 04/02/2024 09:45:00 AM
- Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 03/29/2024 09:45:00 AM
- Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 03/26/2024 09:45:00 AM
- Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 11:30:00 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM